$CHE
CHEMED CORP

2019 Q4 Form 10-K Financial Statement

#000001958421000003 Filed on February 26, 2021

View on sec.gov

Income Statement

Concept 2019 Q4 2018 Q4 2018
Revenue $522.3M $457.5M $1.783B
YoY Change 14.16% 6.79% 6.96%
Cost Of Revenue $347.4M $313.1M $1.228B
YoY Change 10.95% 7.41% 6.7%
Gross Profit $175.0M $144.5M $555.0M
YoY Change 21.11% 5.55% 7.52%
Gross Profit Margin 33.51% 31.58% 31.13%
Selling, General & Admin $79.60M $69.30M $271.2M
YoY Change 14.86% 0.73% -1.97%
% of Gross Profit 45.49% 47.96% 48.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.10M $10.20M $38.86M
YoY Change 38.24% 14.61% 9.09%
% of Gross Profit 8.06% 7.06% 7.0%
Operating Expenses $93.70M $79.30M $271.2M
YoY Change 18.16% 2.06% -1.97%
Operating Profit $81.30M $65.20M $243.6M
YoY Change 24.69% 10.14% 115.54%
Interest Expense -$1.500M -$1.100M $4.990M
YoY Change 36.36% 10.0% 16.81%
% of Operating Profit -1.85% -1.69% 2.05%
Other Income/Expense, Net $0.00 $0.00 $958.0K
YoY Change -88.25%
Pretax Income $79.60M $62.80M $239.6M
YoY Change 26.75% 8.09% 104.93%
Income Tax $14.00M $8.500M $34.06M
% Of Pretax Income 17.59% 13.54% 14.21%
Net Earnings $65.60M $54.30M $205.5M
YoY Change 20.81% -0.55% 109.36%
Net Earnings / Revenue 12.56% 11.87% 11.53%
Basic Earnings Per Share $12.80
Diluted Earnings Per Share $3.952M $3.251M $12.23
COMMON SHARES
Basic Shares Outstanding 16.06M
Diluted Shares Outstanding 16.80M

Balance Sheet

Concept 2019 Q4 2018 Q4 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.200M $4.800M $4.800M
YoY Change 29.17% -56.76% -56.76%
Cash & Equivalents $6.158M $4.831M $4.800M
Short-Term Investments
Other Short-Term Assets $33.20M $29.80M $29.80M
YoY Change 11.41% -35.08% -35.08%
Inventory $7.462M $5.705M $5.700M
Prepaid Expenses $19.15M
Receivables $143.8M $119.5M $119.5M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $190.7M $159.8M $159.8M
YoY Change 19.29% -9.21% -9.2%
LONG-TERM ASSETS
Property, Plant & Equipment $175.8M $162.0M $162.0M
YoY Change 8.47% 13.28% 13.29%
Goodwill $577.4M $510.6M
YoY Change 13.08% 7.06%
Intangibles $126.4M $68.25M
YoY Change 85.15% 24.4%
Long-Term Investments $77.40M $65.60M $65.60M
YoY Change 17.99% 5.64% 5.64%
Other Assets $9.048M $9.209M $9.200M
YoY Change -1.75% 29.21% 29.58%
Total Long-Term Assets $1.078B $815.7M $815.7M
YoY Change 32.11% 9.64% 9.64%
TOTAL ASSETS
Total Short-Term Assets $190.7M $159.8M $159.8M
Total Long-Term Assets $1.078B $815.7M $815.7M
Total Assets $1.268B $975.5M $975.5M
YoY Change 30.01% 6.03% 6.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.10M $50.15M $36.40M
YoY Change 1.9% 3.68% 9.97%
Accrued Expenses $167.4M $111.3M $111.3M
YoY Change 50.4% -0.36% -0.36%
Deferred Revenue
YoY Change
Short-Term Debt $9.800M $13.80M $13.80M
YoY Change -28.99% -9.8% -9.8%
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $262.2M $191.7M $191.7M
YoY Change 36.81% -0.96% -0.93%
LONG-TERM LIABILITIES
Long-Term Debt $90.00M $89.20M $89.20M
YoY Change 0.9% -2.19% -2.19%
Other Long-Term Liabilities $7.883M $17.11M $81.70M
YoY Change -53.93% 3.64% 4.34%
Total Long-Term Liabilities $97.88M $106.3M $170.9M
YoY Change -7.93% -1.3% 0.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $262.2M $191.7M $191.7M
Total Long-Term Liabilities $97.88M $106.3M $170.9M
Total Liabilities $541.7M $384.2M $384.2M
YoY Change 41.0% 1.19% 1.19%
SHAREHOLDERS EQUITY
Retained Earnings $1.426B $1.226B
YoY Change 16.33% 17.97%
Common Stock $896.5M $809.7M
YoY Change 10.72% 10.83%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.598B $1.446B
YoY Change 10.48% 17.46%
Treasury Stock Shares $19.87M $19.44M
Shareholders Equity $726.6M $591.3M $591.3M
YoY Change
Total Liabilities & Shareholders Equity $1.268B $975.5M $975.5M
YoY Change 30.01% 6.03% 6.03%

Cashflow Statement

Concept 2019 Q4 2018 Q4 2018
OPERATING ACTIVITIES
Net Income $65.60M $54.30M $205.5M
YoY Change 20.81% -0.55% 109.36%
Depreciation, Depletion And Amortization $14.10M $10.20M $38.86M
YoY Change 38.24% 14.61% 9.09%
Cash From Operating Activities $63.60M $56.50M $287.1M
YoY Change 12.57% -298.25% 76.71%
INVESTING ACTIVITIES
Capital Expenditures -$13.20M -$16.30M $52.87M
YoY Change -19.02% 15.6% -17.77%
Acquisitions $53.18M
YoY Change 1025.44%
Other Investing Activities $200.0K -$40.00M -$824.0K
YoY Change -100.5% 1279.31% -41.85%
Cash From Investing Activities -$13.10M -$56.30M -$105.2M
YoY Change -76.73% 233.14% 55.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $158.9M
YoY Change 67.88%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -53.50M -62.90M -188.2M
YoY Change -14.94% -266.84% 89.96%
NET CHANGE
Cash From Operating Activities 63.60M 56.50M 287.1M
Cash From Investing Activities -13.10M -56.30M -105.2M
Cash From Financing Activities -53.50M -62.90M -188.2M
Net Change In Cash -3.000M -62.70M -6.290M
YoY Change -95.22% 714.29% 50.16%
FREE CASH FLOW
Cash From Operating Activities $63.60M $56.50M $287.1M
Capital Expenditures -$13.20M -$16.30M $52.87M
Free Cash Flow $76.80M $72.80M $234.3M
YoY Change 5.49% -605.56% 138.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 che Stock Options Forfeiture Rate
StockOptionsForfeitureRate
CY2019 che Stock Options Forfeiture Rate
StockOptionsForfeitureRate
CY2020 che Stock Options Forfeiture Rate
StockOptionsForfeitureRate
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000019584
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45202-4726
CY2020 dei City Area Code
CityAreaCode
513
CY2020 dei Entity File Number
EntityFileNumber
1-8351
CY2020 dei Entity Registrant Name
EntityRegistrantName
CHEMED CORPORATION
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 2600
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
255 East Fifth Street
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Cincinnati
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-0791746
CY2020 dei Local Phone Number
LocalPhoneNumber
762-6690
CY2020 dei Security12b Title
Security12bTitle
Capital Stock – Par Value $1 Per Share
CY2020 dei Trading Symbol
TradingSymbol
CHE
CY2020 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
7056295051
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16032904
CY2020 us-gaap Revenues
Revenues
2079583000
CY2019 us-gaap Revenues
Revenues
1938555000
CY2018 us-gaap Revenues
Revenues
1782648000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1378197000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1321126000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1227644000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
330218000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
305712000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
271209000
CY2020 us-gaap Depreciation
Depreciation
46596000
CY2019 us-gaap Depreciation
Depreciation
40870000
CY2018 us-gaap Depreciation
Depreciation
38464000
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
9987000
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
4335000
CY2018 us-gaap Adjustment For Amortization
AdjustmentForAmortization
399000
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
75095000
CY2019 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-9132000
CY2018 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1300000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
1689903000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
1681175000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
1539016000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
389680000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
257380000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
243632000
CY2020 us-gaap Interest Expense
InterestExpense
2355000
CY2019 us-gaap Interest Expense
InterestExpense
4535000
CY2018 us-gaap Interest Expense
InterestExpense
4990000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8665000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8764000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
958000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
395990000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
261609000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
239600000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76524000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41686000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34056000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
319466000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
219923000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
205544000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
20.02
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
13.77
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.80
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15955000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15969000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16059000
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
19.48
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
13.31
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
12.23
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16398000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16527000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16803000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162675000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6158000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126853000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
143827000
CY2020Q4 us-gaap Inventory Net
InventoryNet
7095000
CY2019Q4 us-gaap Inventory Net
InventoryNet
7462000
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
6603000
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
10074000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
26177000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
23150000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
329403000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
190671000
CY2020Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
88811000
CY2019Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
77446000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
187820000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
175763000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
123448000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
111652000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
118085000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
126370000
CY2020Q4 us-gaap Goodwill
Goodwill
578585000
CY2019Q4 us-gaap Goodwill
Goodwill
577367000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8759000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9048000
CY2020Q4 us-gaap Assets
Assets
1434911000
CY2019Q4 us-gaap Assets
Assets
1268317000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
54234000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
51101000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9464000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
131000
CY2020Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
54703000
CY2019Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
50328000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
91282000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
70814000
CY2020Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
10632000
CY2019Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
6941000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
36200000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39280000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
42593000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
43625000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
299108000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
262220000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
20664000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18504000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
90000000
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
88456000
CY2019Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
76446000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
99210000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7883000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
86656000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
26273000
CY2019Q4 us-gaap Liabilities
Liabilities
541709000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2020Q4 us-gaap Liabilities
Liabilities
533711000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36258638
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35810528
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
36259000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
35811000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
961404000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
860671000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1723777000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1425752000
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20351562
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
19867220
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1822579000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1597940000
CY2020Q4 che Deferred Compensation Payable In Company Stock
DeferredCompensationPayableInCompanyStock
2339000
CY2019Q4 che Deferred Compensation Payable In Company Stock
DeferredCompensationPayableInCompanyStock
2314000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
901200000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
726608000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1434911000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1268317000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
319466000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
219923000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
205544000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56583000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45205000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38863000
CY2020 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
18422000
CY2019 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
14831000
CY2018 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
12611000
CY2020 che Deferred Payroll Taxes
DeferredPayrollTaxes
36350000
CY2020 che Noncash Long Term Incentive Compensation
NoncashLongTermIncentiveCompensation
7208000
CY2019 che Noncash Long Term Incentive Compensation
NoncashLongTermIncentiveCompensation
5740000
CY2018 che Noncash Long Term Incentive Compensation
NoncashLongTermIncentiveCompensation
5405000
CY2020 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
2684000
CY2019 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
6000000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1433000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2770000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5187000
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1171000
CY2019 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
767000
CY2018 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
766000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
306000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
306000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
441000
CY2019 che Loss On Sale Of Transportation Equipment
LossOnSaleOfTransportationEquipment
2266000
CY2018 che Amortization Of Restricted Stock Awards
AmortizationOfRestrictedStockAwards
446000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12773000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19247000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5570000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-367000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1757000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
351000
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3027000
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3491000
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2665000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19096000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28417000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8935000
CY2020 che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
-1206000
CY2019 che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
-3108000
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
13525000
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
161000
CY2018 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
18898000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11834000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11963000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5544000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
12323000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
12354000
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3451000
CY2020 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1237000
CY2019 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1399000
CY2018 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
721000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
489289000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
301249000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
287138000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58831000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53022000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
52872000
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3600000
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
138010000
CY2018 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
53177000
CY2020 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-871000
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-272000
CY2018 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-824000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61560000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-190760000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-105225000
CY2020 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
264900000
CY2019 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
482100000
CY2018 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
406550000
CY2020 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
174900000
CY2019 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
482900000
CY2018 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
469550000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
175594000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
92631000
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
158884000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50382000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
34380000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
32412000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
25328000
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
28474000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
27548000
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21079000
CY2019 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19788000
CY2018 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18662000
CY2020 us-gaap Increase Decrease In Outstanding Checks Financing Activities
IncreaseDecreaseInOutstandingChecksFinancingActivities
-9849000
CY2019 us-gaap Increase Decrease In Outstanding Checks Financing Activities
IncreaseDecreaseInOutstandingChecksFinancingActivities
-3927000
CY2018 us-gaap Increase Decrease In Outstanding Checks Financing Activities
IncreaseDecreaseInOutstandingChecksFinancingActivities
-1531000
CY2018 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
75000000
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
256000
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
478000
CY2018 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1990000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-271212000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-109162000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-188203000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
156517000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1327000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6290000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6158000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4831000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11121000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162675000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6158000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4831000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
540354000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
205544000
CY2018 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.16
CY2018 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
18662000
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
24092000
CY2018 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
158884000
CY2018 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1110000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
591334000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
219923000
CY2019 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.24
CY2019 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19788000
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
27245000
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
92631000
CY2019 us-gaap Stockholders Equity Other
StockholdersEquityOther
525000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
726608000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
319466000
CY2020 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.32
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
21079000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
51855000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
175594000
CY2020 us-gaap Stockholders Equity Other
StockholdersEquityOther
-56000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
901200000
CY2020 us-gaap Nature Of Operations
NatureOfOperations
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">NATURE OF OPERATIONS</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.16in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.09in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We operate through our </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">two</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> wholly-owned subsidiaries: VITAS Healthcare Corporation (“VITAS”) and Roto-Rooter Group, Inc. (“Roto-Rooter”). VITAS focuses on hospice care that helps make terminally ill patients' final days as comfortable as possible. Through its team of doctors, nurses, home health aides, social workers, clergy and volunteers, VITAS provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Through its network of company-owned branches, independent contractors and franchisees, Roto-Rooter offers plumbing, drain cleaning service and water restoration to approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">90</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% of the U.S. population.</span></p>
CY2020 che Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2
CY2020Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
37900000
CY2020 che Deferred Payroll Taxes
DeferredPayrollTaxes
36400000
CY2020 che Deferred Payroll Taxes Short Term Liability
DeferredPayrollTaxesShortTermLiability
18200000
CY2020 che Deferred Payroll Taxes Long Term Liability
DeferredPayrollTaxesLongTermLiability
18200000
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">CONCENTRATION OF RISK</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December 31, 2020, and 2019, approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">74</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">71</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%, respectively, of VITAS’ total accounts receivable balance were from Medicare and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">20</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">26</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">%, respectively, of VITAS’ total accounts receivable balance were due from various state Medicaid or managed Medicaid programs. Combined accounts receivable from Medicare, Medicaid, and managed Medicaid represent approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">80</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% of the consolidated net accounts receivable in the accompanying consolidated balance sheets as of December 31, 2020.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">VITAS has a pharmacy services contract with </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">one</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> service provider for specified pharmacy services related to its hospice operations. A large majority of VITAS’ pharmaceutical purchases are from this vendor. The pharmaceuticals purchased by VITAS are available through many providers in the United States. However, a disruption from VITAS’ main service provider could adversely impact VITAS’ operations, including temporary logistical challenges and increased cost associated with getting medication to our patients. </span></p>
CY2018Q4 us-gaap Goodwill
Goodwill
510570000
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
66726000
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
71000
CY2019Q4 us-gaap Goodwill
Goodwill
577367000
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1193000
CY2020 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
25000
CY2020Q4 us-gaap Goodwill
Goodwill
578585000
CY2020Q4 che Number Of Cloud Computing Arrangements
NumberOfCloudComputingArrangements
2
CY2020 us-gaap Advertising Expense
AdvertisingExpense
54400000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
49500000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
47000000.0
CY2020 che Historical Claims Data Period Of Time
HistoricalClaimsDataPeriodOfTime
P10Y
CY2020 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Period Increase Decrease
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease
-4578000
CY2019 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Period Increase Decrease
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease
-1664000
CY2018 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Period Increase Decrease
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease
-3437000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21338000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19229000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.193
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.159
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.142
CY2020 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
26100000
CY2019 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
24200000
CY2018 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
22900000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">ESTIMATES </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. </span></p>
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1368489000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1334667000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1319851000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1281184000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1223524000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1197562000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
90000000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
90000000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
2028000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
4125000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
4178000
CY2020 che Stock Options Number Of Stock Incentive Plans
StockOptionsNumberOfStockIncentivePlans
3
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5100000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P2Y10M24D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P2Y10M24D
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P2Y10M24D
CY2020 che Share Based Compensation Arrangement By Share Based Payment Award Expiration Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationYear
2022
CY2019 che Share Based Compensation Arrangement By Share Based Payment Award Expiration Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationYear
2021
CY2018 che Share Based Compensation Arrangement By Share Based Payment Award Expiration Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationYear
2020
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26802000
CY2020 che Share Based Compensation Arrangement By Share Based Payment Award Income Tax Benefit Recognized In Income
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncomeTaxBenefitRecognizedInIncome
6904000
CY2019 che Share Based Compensation Arrangement By Share Based Payment Award Income Tax Benefit Recognized In Income
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncomeTaxBenefitRecognizedInIncome
5373000
CY2018 che Share Based Compensation Arrangement By Share Based Payment Award Income Tax Benefit Recognized In Income
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncomeTaxBenefitRecognizedInIncome
4788000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
125448000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
106793000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
102144000
CY2020 che Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalIntrinsicValue
1171000
CY2019 che Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalIntrinsicValue
767000
CY2018 che Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalIntrinsicValue
4003000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
466.43
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
331.69
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
333.75
CY2020Q4 che Stock Price On Date Of Issuance
StockPriceOnDateOfIssuance
471.74
CY2019Q4 che Stock Price On Date Of Issuance
StockPriceOnDateOfIssuance
413.19
CY2018Q4 che Stock Price On Date Of Issuance
StockPriceOnDateOfIssuance
306.70
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
97.56
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
78.06
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
67.16
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
298670
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
287010
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
246350
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0024
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0165
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0299
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2841
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2125
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2242
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.003
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.003
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.004
CY2020 us-gaap Interest Expense
InterestExpense
2355000
CY2019 us-gaap Interest Expense
InterestExpense
4535000
CY2018 us-gaap Interest Expense
InterestExpense
4990000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76524000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41686000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34056000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
319466000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
219923000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
205544000
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
757000
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
513000
CY2018 us-gaap Investment Income Net
InvestmentIncomeNet
671000
CY2020Q4 us-gaap Assets
Assets
1434911000
CY2019Q4 us-gaap Assets
Assets
1268317000
CY2018Q4 us-gaap Assets
Assets
975529000
CY2020 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
61793000
CY2019 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
189024000
CY2018 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
105883000
CY2020 che Depreciation Amortization Of Intangibles And Stock Award
DepreciationAmortizationOfIntangiblesAndStockAward
56583000
CY2019 che Depreciation Amortization Of Intangibles And Stock Award
DepreciationAmortizationOfIntangiblesAndStockAward
45205000
CY2018 che Depreciation Amortization Of Intangibles And Stock Award
DepreciationAmortizationOfIntangiblesAndStockAward
38863000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10000000.0
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4300000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
399000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
10041000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
10016000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9963000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9916000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
9902000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
11705000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
109150000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
47607000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
61543000
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
165692000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
47607000
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
118085000
CY2019 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
14.34
CY2018 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
14.00
CY2019 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
13.85
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
108250000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37620000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
70630000
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
163990000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37620000
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
126370000
CY2019 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1995688000
CY2018 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1900218000
CY2019 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
228939000
CY2018 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
224851000
CY2018 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
13.38
CY2020Q4 che Payment Of Liabilities Discounted Operations Year One
PaymentOfLiabilitiesDiscountedOperationsYearOne
826000
CY2020Q4 che Payment Of Liabilities Discounted Operations Year Two
PaymentOfLiabilitiesDiscountedOperationsYearTwo
300000
CY2020Q4 che Payment Of Liabilities Discounted Operations Thereafter
PaymentOfLiabilitiesDiscountedOperationsThereafter
601000
CY2020Q4 che Total Estimated Timing Of Payments Of Liabilities Related To Discontinued Operations
TotalEstimatedTimingOfPaymentsOfLiabilitiesRelatedToDiscontinuedOperations
1727000
CY2020Q4 che Capitalized Property And Equipment Not Paid
CapitalizedPropertyAndEquipmentNotPaid
3900000
CY2019Q4 che Capitalized Property And Equipment Not Paid
CapitalizedPropertyAndEquipmentNotPaid
1800000
CY2018Q4 che Capitalized Property And Equipment Not Paid
CapitalizedPropertyAndEquipmentNotPaid
3200000
CY2020Q4 che Cash Overdraft Payable Included In Accounts Payable
CashOverdraftPayableIncludedInAccountsPayable
0
CY2019Q4 che Cash Overdraft Payable Included In Accounts Payable
CashOverdraftPayableIncludedInAccountsPayable
9800000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
100000
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
100000
CY2020 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
7933000
CY2019 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
8254000
CY2018 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
287000
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
757000
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
513000
CY2018 us-gaap Investment Income Net
InvestmentIncomeNet
671000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8665000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8764000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
958000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
58602000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
36779000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
23934000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
15950000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
7078000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4484000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
539000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
600000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
452000
CY2020 che Deferred Federal State And Local Income Tax Expense Benefit
DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
1456000
CY2019 che Deferred Federal State And Local Income Tax Expense Benefit
DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
-2773000
CY2018 che Deferred Federal State And Local Income Tax Expense Benefit
DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
5185000
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-23000
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
2000
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
1000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76524000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41686000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34056000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
77834000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
40619000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
39377000
CY2020Q4 che Deferred Tax Liabilities Right Of Use Lease Assets
DeferredTaxLiabilitiesRightOfUseLeaseAssets
32788000
CY2019Q4 che Deferred Tax Liabilities Right Of Use Lease Assets
DeferredTaxLiabilitiesRightOfUseLeaseAssets
28807000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
42151000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
32498000
CY2020Q4 che Deferred Tax Assets Tax Deferred Expense Lease Liabilities
DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities
35888000
CY2019Q4 che Deferred Tax Assets Tax Deferred Expense Lease Liabilities
DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities
32476000
CY2020Q4 che Deferred Tax Assets Implicit Price Concessions
DeferredTaxAssetsImplicitPriceConcessions
7031000
CY2019Q4 che Deferred Tax Assets Implicit Price Concessions
DeferredTaxAssetsImplicitPriceConcessions
4165000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4047000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5425000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2030000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2678000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
888000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
592000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
92035000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
31686000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
21942000
CY2020Q4 us-gaap Deferred Tax Liabilities Regulatory Assets
DeferredTaxLiabilitiesRegulatoryAssets
3921000
CY2019Q4 us-gaap Deferred Tax Liabilities Regulatory Assets
DeferredTaxLiabilitiesRegulatoryAssets
2510000
CY2020Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
2382000
CY2019Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
2058000
CY2020Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
1161000
CY2019Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
1477000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
142000
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
167000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
112699000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
96338000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
20664000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
18504000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
37300000
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
43100000
CY2020Q4 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Domestic Subsidiaries
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfDomesticSubsidiaries
8400000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
481200000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
445903000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
293380000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1323000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1348000
CY2020Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
163000
CY2019Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
159000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.193
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.159
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.142
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
270140000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1323000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1348000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1123000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
200000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
234000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
453000
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
219000
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
259000
CY2018 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
228000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1304000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
83158000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
54938000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
50316000
CY2020 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
26089000
CY2019 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
24177000
CY2018 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
22862000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
13855000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
7880000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
7150000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
5377000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
3048000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2280000
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
223000
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-3000
CY2018 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-2828000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76524000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41686000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34056000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
61517000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
44063000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
9749000
CY2020Q4 us-gaap Undistributed Earnings Of Domestic Subsidiaries
UndistributedEarningsOfDomesticSubsidiaries
35100000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
187820000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
175763000
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
8900000
CY2019Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
9600000
CY2020 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
5500000
CY2019 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
4600000
CY2018 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
5400000
CY2020 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
up to 5 years
CY2020 us-gaap Lessee Operating Lease Option To Terminate
LesseeOperatingLeaseOptionToTerminate
within 1 year
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
123448000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
111652000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
36200000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39280000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
99210000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
43437000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
31059000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
24174000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
86656000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
135410000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
125936000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
12175000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
18614000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
147702000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10356000
CY2020Q4 che Lessee Operating Lease Future Lease Obligations Not Yet Commenced
LesseeOperatingLeaseFutureLeaseObligationsNotYetCommenced
1936000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
135410000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
60195000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
49112000
CY2020 us-gaap Sublease Income
SubleaseIncome
83000
CY2019 us-gaap Sublease Income
SubleaseIncome
6000
CY2020 us-gaap Lease Cost
LeaseCost
60112000
CY2019 us-gaap Lease Cost
LeaseCost
49106000
CY2020Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
74262
CY2020Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
2300000
CY2019Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
77963
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
49932000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
41525000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
58802000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
150356000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y11M23D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0287
CY2020 che Operating Lease Payments Include To Extended Lease Terms
OperatingLeasePaymentsIncludeToExtendedLeaseTerms
2300000
CY2020Q4 che Lessee Operating Lease Future Lease Obligations Not Yet Commenced
LesseeOperatingLeaseFutureLeaseObligationsNotYetCommenced
1900000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
18243000
CY2020 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
27044000
CY2019 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
25529000
CY2018 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
16502000
CY2019Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
2300000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
319466000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15955000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
20.02
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
368000
CY2020 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
75000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
319466000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16398000
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
19.48
CY2019 us-gaap Net Income Loss
NetIncomeLoss
219923000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15969000
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
13.77
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
480000
CY2019 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
78000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
219923000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16527000
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
13.31
CY2018 us-gaap Net Income Loss
NetIncomeLoss
205544000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16059000
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.80
CY2018 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
650000
CY2018 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
94000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
205544000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16803000
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
12.23
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
566000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
287000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
246000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
175594000
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
92631000
CY2018 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
158884000
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
384252
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
269009
CY2018 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
561146
CY2020 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
456.98
CY2019 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
344.34
CY2018 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
283.14
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
250000000.0
CY2020Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
178400000
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
75095000
CY2019 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-9132000
CY2018 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1300000

Files In Submission

Name View Source Status
che-20201231xex24.htm Edgar Link pending
0000019584-21-000003-index-headers.html Edgar Link pending
0000019584-21-000003-index.html Edgar Link pending
0000019584-21-000003.txt Edgar Link pending
0000019584-21-000003-xbrl.zip Edgar Link pending
che-20201231.xsd Edgar Link pending
che-20201231x10k.htm Edgar Link pending
che-20201231x10k_htm.xml Edgar Link completed
che-20201231xex21.htm Edgar Link pending
che-20201231xex23.htm Edgar Link pending
che-20201231xex31_1.htm Edgar Link pending
che-20201231xex31_2.htm Edgar Link pending
che-20201231xex31_3.htm Edgar Link pending
che-20201231xex32_1.htm Edgar Link pending
che-20201231xex32_2.htm Edgar Link pending
che-20201231xex32_3.htm Edgar Link pending
che-20201231_cal.xml Edgar Link unprocessable
che-20201231_def.xml Edgar Link unprocessable
che-20201231_lab.xml Edgar Link unprocessable
che-20201231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending